Kyle K Nishiyama1, Adi Cohen, Polly Young, Ji Wang, Joan M Lappe, X Edward Guo, David W Dempster, Robert R Recker, Elizabeth Shane. 1. Division of Endocrinology (K.K.N., A.C., P.Y., E.S.), Department of Medicine, and Department of Pathology (D.W.D.), College of Physicians and Surgeons, Columbia University, New York, New York 10032; Department of Biomedical Engineering (J.W., X.E.G.), Columbia University, New York, New York 10027; and Division of Endocrinology (J.M.L., R.R.R.), Department of Medicine, Creighton University, Omaha, Nebraska 68131.
Abstract
CONTEXT: In premenopausal women with idiopathic osteoporosis (IOP), treatment with teriparatide leads to substantial improvement in bone density and quality at central skeletal sites. The effects of teriparatide may differ on cortical and trabecular bone and also at the central and the peripheral skeleton. OBJECTIVE: The objective of the study was to determine whether teriparatide was associated with improvements in compartmental volumetric bone mineral density (BMD), bone microarchitecture, and estimated bone strength of the distal radius and tibia as assessed by high-resolution peripheral quantitative computed tomography. DESIGN, SETTING, AND PARTICIPANTS: Premenopausal women (n = 20, age 41 ± 5 y) with IOP (low trauma fractures and/or Z-scores ≤ -2.0) were scanned with high-resolution peripheral quantitative computed tomography at baseline and after 18 months of teriparatide treatment. Cortical and trabecular volumetric BMD and microarchitecture were measured by both standard and advanced techniques, including individual trabecula segmentation, and bone strength was estimated by finite element analysis. MAIN OUTCOME MEASURES: The total volumetric BMD and homogeneous bone stiffness were measured. RESULTS: Trabecular volumetric BMD increased significantly by 2.6% (1.8, 6.2) [median (interquartile range)] at the radius and 2.5% (1.1, 3.6) at the tibia. In addition, trabecular plate bone volume fraction increased by 9.1% (2.1, 17.1) at the radius and 7.6% (1.0, 9.7) at the tibia. Cortical thickness and volumetric density did not change; however, cortical porosity increased at the radius but not at the tibia. Despite these changes, whole-bone stiffness and failure load estimated by finite element analysis increased at both the radius and tibia. CONCLUSIONS: In premenopausal women with IOP, 18 months of teriparatide was associated with increases in trabecular volumetric BMD, improved trabecular microarchitecture, and estimated bone strength at both the radius and tibia.
CONTEXT: In premenopausal women with idiopathic osteoporosis (IOP), treatment with teriparatide leads to substantial improvement in bone density and quality at central skeletal sites. The effects of teriparatide may differ on cortical and trabecular bone and also at the central and the peripheral skeleton. OBJECTIVE: The objective of the study was to determine whether teriparatide was associated with improvements in compartmental volumetric bone mineral density (BMD), bone microarchitecture, and estimated bone strength of the distal radius and tibia as assessed by high-resolution peripheral quantitative computed tomography. DESIGN, SETTING, AND PARTICIPANTS: Premenopausal women (n = 20, age 41 ± 5 y) with IOP (low trauma fractures and/or Z-scores ≤ -2.0) were scanned with high-resolution peripheral quantitative computed tomography at baseline and after 18 months of teriparatide treatment. Cortical and trabecular volumetric BMD and microarchitecture were measured by both standard and advanced techniques, including individual trabecula segmentation, and bone strength was estimated by finite element analysis. MAIN OUTCOME MEASURES: The total volumetric BMD and homogeneous bone stiffness were measured. RESULTS: Trabecular volumetric BMD increased significantly by 2.6% (1.8, 6.2) [median (interquartile range)] at the radius and 2.5% (1.1, 3.6) at the tibia. In addition, trabecular plate bone volume fraction increased by 9.1% (2.1, 17.1) at the radius and 7.6% (1.0, 9.7) at the tibia. Cortical thickness and volumetric density did not change; however, cortical porosity increased at the radius but not at the tibia. Despite these changes, whole-bone stiffness and failure load estimated by finite element analysis increased at both the radius and tibia. CONCLUSIONS: In premenopausal women with IOP, 18 months of teriparatide was associated with increases in trabecular volumetric BMD, improved trabecular microarchitecture, and estimated bone strength at both the radius and tibia.
Authors: Adi Cohen; Emily M Stein; Robert R Recker; Joan M Lappe; David W Dempster; Hua Zhou; Serge Cremers; Donald J McMahon; Thomas L Nickolas; Ralph Müller; Alexander Zwahlen; Polly Young; Julie Stubby; Elizabeth Shane Journal: J Clin Endocrinol Metab Date: 2013-03-29 Impact factor: 5.958
Authors: E S Orwoll; W H Scheele; S Paul; S Adami; U Syversen; A Diez-Perez; J M Kaufman; A D Clancy; G A Gaich Journal: J Bone Miner Res Date: 2003-01 Impact factor: 6.741
Authors: Houchen Lyu; Sizheng S Zhao; Kazuki Yoshida; Sara K Tedeschi; Chang Xu; Sagar U Nigwekar; Benjamin Z Leder; Daniel H Solomon Journal: J Clin Endocrinol Metab Date: 2019-11-01 Impact factor: 5.958
Authors: Joy N Tsai; Alexander V Uihlein; Sherri-Ann M Burnett-Bowie; Robert M Neer; Yuli Zhu; Nicholas Derrico; Hang Lee; Mary L Bouxsein; Benjamin Z Leder Journal: J Bone Miner Res Date: 2015-01 Impact factor: 6.741
Authors: Adi Cohen; Mafo Kamanda-Kosseh; Robert R Recker; Joan M Lappe; David W Dempster; Hua Zhou; Serge Cremers; Mariana Bucovsky; Julie Stubby; Elizabeth Shane Journal: J Clin Endocrinol Metab Date: 2015-09-10 Impact factor: 5.958
Authors: Deborah M Mitchell; Padrig Tuck; Kathryn E Ackerman; Natalia Cano Sokoloff; Ryan Woolley; Meghan Slattery; Hang Lee; Mary L Bouxsein; Madhusmita Misra Journal: Bone Date: 2015-06-27 Impact factor: 4.398
Authors: Bin Zhou; Zhendong Zhang; Ji Wang; Y Eric Yu; Xiaowei Sherry Liu; Kyle K Nishiyama; Mishaela R Rubin; Elizabeth Shane; John P Bilezikian; X Edward Guo Journal: Pattern Recognit Lett Date: 2015-04-01 Impact factor: 3.756